FDA Commissioner Gottlieb announced last week it “would create the new Office of Clinical Policy and Programs and the Office of Food Policy and Response. The former office would handle orphan products, pediatric therapeutics and combination products.”
“The Office of the Chief Scientist is slated to oversee offices for minority and women’s health (which previously reported directly to the commissioner). And the domestic and global policy groups will be merged under the Office of Policy, Legislation and International Affairs.”
The proposal “doesn’t require Congressional approval. If approved, the changes will be put into effect in October.” Read the full post here.
Source: FDA Commissioner to shuffle its offices – By Darius Tahir, July 20, 2018. POLITICO Morning eHealth.
